Mangalam Drugs and Organics Ltd (MANGALAM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.89",
    "chg": -0.42,
    "chgp": "-1.3%",
    "dir": -1,
    "prev_price": "32.31",
    "mcapval": "50.48 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Sep 24, 12:51 PM",
    "curr_time": "12:52 PM",
    "last_traded_at": "Sep 24, 12:51 PM IST",
    "bse_nse_vol": "24.74 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4197354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MangalamDrugsan_mojoScore_4197354.png",
        "date": "2026-09-18 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4189481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MangalamDrugsan_stocks_hitting_upper_circuit_4189481.png",
        "date": "2026-09-10 12:00:08",
        "description": "At Rs 34.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4170082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MangalamDrugsan_mojoScore_4170082.png",
        "date": "2026-08-26 10:10:40",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 9.57% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4167019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MangalamDrugsan_stocks_hitting_upper_circuit_4167019.png",
        "date": "2026-08-24 13:00:05",
        "description": "At Rs 30.44, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 9.57% on 24 Aug 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4150072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MangalamDrugsan_mojoScore_4150072.png",
        "date": "2026-08-12 10:11:22",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing."
      },
      {
        "title": "When is the next results date for Mangalam Drugs and Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mangalam-drugs-and-organics-ltd-4140503",
        "imagepath": "",
        "date": "2026-08-06 23:18:53",
        "description": "The next results date for Mangalam Drugs and Organics Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4125758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_mojoScore_4125758.png",
        "date": "2026-07-29 10:10:57",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4103683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_mojoScore_4103683.png",
        "date": "2026-07-15 10:11:02",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 15 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 2.84% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4103464",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_stocks_hitting_upper_circuit_4103464.png",
        "date": "2026-07-15 10:00:07",
        "description": "At Rs 28.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 2.84% on 15 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 210,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of LODR For Appointment Of Mr. Prabhakar Zavar As Additional Indepedent Director ( Non-Executive) For Term Of 5 Years Wef. 15/09/2026 Subject To Consent Of Shareholders At Ensuin",
      "datetime": "15-Sep-2026",
      "details": "Outcome of Board Meeting pursuant to Regulation 30 of LODR for appointment of Mr. Prabhakar Raghunath Zavar as the Additional Indepedent Director ( Non- Executive) for term of 5 years wef. September 15th 2026 subject to consent of shareholders at ensuing EGM.",
      "source": "BSE"
    },
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure",
      "datetime": "15-Sep-2026",
      "details": "Subsequent Disclosure under Regulation 30 Para A of Schedule III of LODR 2015 for the bank default of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "15-Sep-2026",
      "details": "Disclosure under Regulation 30 of LODR 2015 for the appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as the Additional Independent Director ( Non- Executive) for term of 5 years wef. 15/09/2026 at the Board Meeting held on today Tuesday September 15th 2026 subject to consent of Shareholders at the ensuing EGM.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-09-18 10:10:25

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 10% Gain — Buyers Queue, Sellers Absent

2026-09-10 12:00:08

At Rs 34.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 10% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-08-26 10:10:40

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 26 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 9.57% Gain — Buyers Queue, Sellers Absent

2026-08-24 13:00:05

At Rs 30.44, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 9.57% on 24 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-08-12 10:11:22

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 12 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing.

Read full news article

When is the next results date for Mangalam Drugs and Organics Ltd?

2026-08-06 23:18:53

The next results date for Mangalam Drugs and Organics Ltd is scheduled for 12 August 2026....

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-07-29 10:10:57

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-07-15 10:11:02

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 15 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.

Read full news article

Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 2.84% Gain — Buyers Queue, Sellers Absent

2026-07-15 10:00:07

At Rs 28.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 2.84% on 15 Jul 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News